Company Filing History:
Years Active: 2006
Title: **Edgar Meinl: Innovator in T Cell Research**
Introduction
Edgar Meinl, an accomplished inventor based in Krailling, Germany, has made significant contributions to the field of immunology. With a focus on antigen-specific and activated T lymphocytes, he has developed pioneering methods that promise advancements in both diagnostic and therapeutic applications.
Latest Patents
Meinl holds a patent titled "Antigen-specific, activated T lymphocytes, detection and use." This invention delves into autoreactive peptides, peptide-MHC complexes, and T cell subpopulations that exhibit specific reactivity. The implications of this research are profound, paving the way for improved diagnosis and treatment of various immune-related conditions.
Career Highlights
Edgar Meinl is affiliated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work sets a benchmark in the industry, showcasing innovation and dedication to enhancing healthcare solutions. Over the years, his research has contributed to a deeper understanding of immune responses.
Collaborations
During his career, Meinl has collaborated with esteemed colleagues, including Josef Endl and Peter Stahl. These partnerships have helped refine his research and bolster the impact of his findings on the scientific community.
Conclusion
Edgar Meinl's contributions to immunology through his patent reflect his innovative spirit and dedication to advancing medical science. Through his work at Roche Diagnostics GmbH and collaborations with talented colleagues, he continues to influence the trajectory of T cell research, promising better diagnostics and therapeutic solutions for the future.